Get started
Live feed
·
INSIDERFilingvia Quantisnow
Acrivon Therapeutics Inc. logo

Director Shacham Sharon was granted 9,366 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ACRVAcrivon Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRV (Acrivon Therapeutics Inc.) and more on Quantisnow.